Citi lowered the firm’s price target on Reckitt Benckiser to 5,500 GBp from 5,900 GBp and keeps a Buy rating on the shares. The analyst believes the stock’s catalyst path remains complicated with a likely weak Q1 and the market putting a “sticky liability discount” on the name. However, beyond Q1, the risk/reward could turn more favorable with a valuation discount “likely to have overshot” and the increasing need for strategic decisions on portfolio and capital allocation should the turnaround fail, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on RBGLY:
- Reckitt Benckiser upgraded to Outperform from Neutral at Exane BNP Paribas
- Reckitt Benckiser price target lowered to 4,000 GBp from 4,600 GBp at Jefferies
- Reckitt stands by safety of formula, ‘strongly disagrees’ with jury decision
- Reckitt Benckiser plunges after jury awards $60M damages in formula verdict
- Reckitt Benckiser price target lowered to 6,500 GBp from 7,000 GBp at JPMorgan